Member Info for MrRipley

Jupiter are one of the worst performing funds out there. So any suggestion that they have a clue what’s going on is total crap. They’ve called it so far but to suggest they’re ahead of the current is utter fear mongering *******s. To suggest that they would never increase a short to suppress a rise and keep sentiment where it is, frustrated, is also *******s. Of course they would. It’s just a pump and dump in reverse.

Not sure you’re qualified to give advice here ADV, HE1 Dacia. Perhaps sit quietly in the corner before you cost us all a fortune.

Think they’ve got about 2.5 million or so shares on the never never. W4nkers. Would create a fair updraft if they were to close considering that’s about an average days trading volume usually about 50/50 buys to sells at the minute so they’d need to buy every single bought share for about 10 standard days of trading to get out clean. Except that wouldn’t happen. And they’d need to disclose with each reduction, which would cause more of a rise. So basically they need bad news to get out clean. If they want out now then they need to be prepared to lose some gains.

PL, I believe it will get to market, as you said via a big pharma company too. I don’t believe there will be any attempt to shelve it as it isn’t a case of it reducing the need for Doxorubicin, it actually creates a higher demand through larger doses. Any company currently selling doxorubicin would essentially be buying a tenner for a fiver.

If this all goes well, one day you will say to your loved ones “imagine if we’d put x amount in, we’d be worth x millions now”…. IF all goes well. For balance.

It’s a funny one this isn’t it really. If it works it’s worth billions. Even with a potential fundraise and dilution it’s worth a fortune in what the rag tag will call bags. If TMAC works it’s worth a lot more billions. If AVA works it’ll fund TMAC through clinic. If they both work they can massively expand the company and Affimers will fly off the shelves. If all 3 IPs are a success, PreCision works, Affimers help TMAC to work, Daewoong, Point and LG have success via our license deals, then how many billions is this worth? Anyone? The target markets are 1.5bn and growing for AVA6k, 56.5b pa for PreCision as a whole at 10% of the market, 200bn per annum for therapeutics inc both platforms and a 100bn market pa for MAbs disruption with Affimers. If we get dilution then it’ll be painful for a short while. We may as has been pointed out get funding via a license deal for Val or Dox. We really don’t know. But we need a very small amount of success here to make the current situation seem quite amusing one day.

Amazing wyntwat insight as always. See how he links the value directly to AVA6000 now. Not to the cash we have in the bank, the deals with LG, Daewoong or Point, nor does he place any value on either of our Other 2 IPs. Jupiter do not want a change in sentiment. If we become positive then the price rises and their short fails. The SP should now be over £1. Step one was can we dose patients safely at any volume at all, and the answer is yes. That’s a fundamentally amazing step. AVA6000 is not going to kill a persons at close to the standard dose. Tick. We didn’t know that before. It couldn’t possibly have been priced in. The dose is now moving to 130% of the standard safe dose of Dox. The SP meanwhile hasn’t reacted. Take away the SP suppression of Jupiter and we’d be a little further north and the likes of Wynbore would still be in and ramping as he was yesterday. This share is not as simple as cash burn plus a one cherry picked fundamental equals this. It’s the sum of all parts and I’m sorry but the likes of a poster who actually pushed people to buy ADV and HE1, 2 of the biggest dusters in recent memory should absolutely 100% not be listened to ever, at all. Not unless you want to lose a fortune.

I was going to say yesterday that I reckon that’s what was going on. It would explain the stifled price and a bash to sentiment. Take a positive day and throw an anchor onto it and watch the share holders become dejected. They are genuine scum bags. You know when they decide to buy back they’ll go long and make it in both directions.

Agreed Runner. I think what we need now is our annual report so we can get an idea of our current cash position. I feel that can be their last bet for now, hoping there’s £6.50 left and a couple of euros from their last holiday. That would signal an imminent fundraise. If the position is strong then it wouldn’t. An announcement of an IP on nasdaq or a license deal for Dox or Val would also bin that plan too. Long term we would need terrible AVA news. It’s become a very high risk play for them as sentiment moves firmly into oncology and so far that’s very very positive. The next few weeks will be telling. First stop, above £1 and some stability and let’s see what the roadshow brings in terms of new II’s

I asked this question on Twitter directly @jupiter, then tagged Boris etc into the whole partying and LFT scandal with some saucy pre 1066 language and I was promptly banned for life. They are, in the most literal sense, banking on chemotherapy stating precisely at this level of horrific through Avactas failure. Then they all go home and kiss their wives and children goodnight and knock back a few bottles of I can’t believe it’s not Babycham.

https://shorttracker.co.uk/company/GB00BYYW9G87/

Brontë and Jupiter still short. It’ll interesting to see how this plays out next week. Will there be much interest from IIs? Will we continue to bounce around sub £1. Theres circa 3.5m shares required by these two companies combined to close their short. How much is that amount of buying worth to the SP? Even spread over a few days it would be a lot of blue and would pull in a lot of PI buyers on positive sentiment pushing the SP even higher. I believe their averages (I’ve been corrected on this) are around 1.15 for Brontë and 1.25-1.30 for Jupiter. So 24p ish to put pressure on Brontë, or 27 or so % of there current SP. If we get ii interest and Jupiter and Brontë begin to close the upward pressure would be fantastic and easily enough to rip the majority of their profit from them. A couple of IIs interested would certainly make it a real poor day for Brontë. Anyway we shall see. Of course I’m of the position where I intend to hold as long as I don’t need the cash for anything else. I’m hoping by the time I sell in a few years it should be just enough to pay to have one hot shower a week based on current price hikes. A few hundred grand should do it.

That isn’t a buy I’m afraid champ. 17:05-17:10 is generally the spread betters shuffling their underpants after a hard days robbery.

But other than that I totally agree.

The employee who took their 400k share option totally agrees.

“I very much doubt if we’ll hear any news about this trial until the full results are published. Anything else might risk false hope and/or false negative results.”

This is you when trials started. Today we’ve got DE. I can’t wait for more if you’re awesome predictions. It’s amusing that pointing out that someone is stupid is bullying. You could argue I’m helping you out, that way you can get a special helmet and a warning to people to keep their fingers away from your mouth. You’re welcome bud.

Toodle pip.

Thanks Woland one. Im touched….

Weren’t you on Twitter announcing you had a short on Avacta? Anyway, as I said, if you think that as we get multiple pieces of data via RNS at each cohort and escalation and if they are all positive you think this will be sub 120 then you’re truly thick. You’re being objectively negative while playing make believe you’re a holder. You carry on being a twat. It makes no odds to me.

03-Feb-22 12:55:50 91.50 142,076 Buy* 130.00k O

Fair old order been filled or large buy. Maybe The Reverend Rich Ken is back.

RD, exactly. The majority of short term holders can’t grasp the possible size of the target market. Or they simply don’t want to even consider holding for more than the very near future, even if within the next 12 months, or half of the LFT debacle, we’ll have a lot more data and could be 5 times higher than today. IIs though will not be here for just 10-20% spikes and the SP will become a lot stronger as the traders are replaced. In my opinion. Could be totally wrong though, we could plummet into the ground like a dart as it’s revealed AS is a compulsive gambler and has blown all the funding betting on dwarf tossing contests after it’s revealed the competitor he chose wasn’t tossing a dwarf, but his much lighter 5 year old niece. It could happen. As Wyntwunt says, you have to be balanced.

They already won did they wyndrone? How? Their shorts are still open. So unless they close below their average they haven’t won at all. Once again, wrong.

Big pharma won’t crush this if it works. They’ll want to make money from it. It will increase the market size. I don’t believe we’ll be independent very long.